Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Virological Methods|January 1, 1996
Detection of Tospovirus species by RT-PCR of the N-gene and restriction enzyme digestions of the productsR A Dewey, L C Semorile, O GrauMolecular Phylogenetics and Evolution|August 1, 1997
Cladistic analysis of Tospovirus using molecular charactersR A Dewey, L C Semorile, O Grau, et al.Cancer Gene Therapy|March 10, 2012
Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapyF Noyan, I Avedillo Díez, M Hapke, et al.Gene Therapy|June 6, 1998
FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectorsA T Larregina, A E Morelli, R A Dewey, et al.Clinical and Experimental Immunology|January 5, 2013
Cell-based interventions to halt autoimmunity in type 1 diabetes mellitusA E Barcala Tabarrozzi, C N Castro, R A Dewey, et al.The Journal of General Virology|March 26, 1999
Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicityA E Morelli, A T Larregina, J Smith-Arica, et al.Clinical and Experimental Immunology|March 18, 2014
Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetesC N Castro, A E Barcala Tabarrozzi, J Winnewisser, et al.Nature Medicine|November 5, 1999
Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trialsR A Dewey, G Morrissey, C M Cowsill, et al.Gene Therapy|May 9, 2000
Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TKC Cowsill, T D Southgate, G Morrissey, et al.The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomasS Windeatt, T D Southgate, R A Dewey, et al.Pageof 1